Spyre Therapeutics(SYRE)
WALTHAM, MA
BiotechnologyFocus: Antibodies
Spyre Therapeutics is a life sciences company focused on Antibodies.
Immunology
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
SPY002-091
HealthyClinical Trials (1)
NCT06672718A Study of SPY002-091 in Healthy Volunteers
Phase 1SPY003-207
HealthyClinical Trials (1)
NCT06873724SPY003-207 in Healthy Volunteers
Phase 1SPY001-001
HealthyClinical Trials (1)
NCT06448247A Study of SPY001-001 in Healthy Volunteers
Phase 1SPY002-072
HealthyClinical Trials (1)
NCT06622070A Study of SPY002-072 in Healthy Volunteers
Phase 1SPY002-072
Rheumatoid ArthritisClinical Trials (1)
NCT07148414A Study of SPY072 in Rheumatic Disease
Phase 2SPY001
Ulcerative ColitisClinical Trials (1)
NCT07012395A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Phase 2Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 6 clinical trials
SEC Filings: 2 available
Financials (FY2025)
Revenue
$886K62%
R&D Spend
$90M(10102%)53%
Net Income
-$339MCash
$189MHiring Trend
Stable
0
Open Roles
+0
Added
-0
Filled/Removed
Based on last 4 crawl cycles